Matthew Lederman, MD
Note: This provider is a member of Reproductive Medicine Associates of New York - Westchester (RMA). Please note that as a RMA physician, this provider is not a part of Optum and their insurance may differ from Optum's accepted insurance.
Dr. Matthew Lederman is a board-certified Reproductive Endocrinologist and Infertility Specialist, and Practice Director of RMA of New York – Westchester, and Tissue Bank Director of the Mount Kisco location. Dr. Lederman is often acknowledged for his compassionate care, devotion to patients, and his clinical expertise. He treats patients at the Mount Kisco, White Plains, and Poughkeepsie locations.
Prior to joining RMA of New York in 2014, Dr. Lederman treated patients at the Continuum Reproductive Center at St. Luke's Roosevelt Hospital Center. After graduating from the University of Michigan, Dr. Lederman received his medical degree from the Chicago Medical School and completed his residency in Obstetrics and Gynecology as well as his fellowship in Reproductive Endocrinology and Infertility at the Albert Einstein College of Medicine/Montefiore Medical Center. During his residency, he served as administrative chief resident and also received the Albert Einstein College of Medicine of Yeshiva University Teaching Award two years in a row. While in fellowship, Dr. Lederman was acknowledged by the Endocrine Society for his research and received a travel grant. He serves on the Medical Advisory Board of FORCE: Facing our Risk of Cancer Empowered, the Scientific Advisory Board for TEAL: Tell Every Amazing Lady About Ovarian Cancer, and is a fellow of the American College of Obstetricians and Gynecologists. He is a member of the American Society for Reproductive Medicine, Society of Reproductive Endocrinology and Infertility, Endocrine Society, Westchester OB/GYN Society, and RESOLVE.
Dr. Lederman has been recognized by Super Doctors and featured in New York Times Magazine in their New York Edition consistently since 2015. Dr. Lederman has also been named as a Top Doctor by Castle Connolly and New York magazine since 2019, and by America's Most Honored Doctors since 2020. Dr. Lederman has published scientific abstracts and articles in peer-reviewed journals in the fields of endocrinology and infertility, and has presented his research at national conferences. He has extensive clinical experience in all areas of fertility, including unexplained infertility, recurrent pregnancy loss, in vitro fertilization (IVF), egg freezing, pre-implantation genetic testing, and fertility preservation for patients recently diagnosed with cancer (oncofertility) and those who are predisposed to hereditary cancer syndromes (e.g. BRCA).
- Castle Connolly Top Doctor: 2021
- Undergraduate & Graduate
- University of Michigan, Ann Arbor MI: 1998
- Medical Education
- Finch Univ. of Health Sciences/The Chicago Medical School, North Chicago IL: 2002
- Albert Einstein College of Medicine/Montefiore Medical Center, Bronx NY: 2006
- Albert Einstein College of Medicine, Bronx NY: 2009 Reproductive Endocrinology and Infertility
- Board Certifications
- Obstetrics & Gynecology
- Reproductive Endocrinology and Infertility
- American College of Obstetrics & Gynecology
- Fellow American Society for Reproductive Medicine Society for Reproductive Endocrinology & Infertility
- The Endocrine Society
- Westchester OB/GYN Society
Herlihy N, Sekhon L, Oliva M, Gounko D, Lee J, Lekovich J, Lederman M, Copperman AB. How do ovarian reserve and aneuploidy in BRCA carriers compare to that of the general population undergoing art? Fertility and Sterility 2018; 110: e177-e178.
Sekhon L, Herlihy N, Lee J, Friedman S, Stein D, Copperman AB, Lederman M. Knowledge, attitudes, and concerns of individuals with cancer-predisposing mutations regarding fertility preservation and preimplantation genetic testing. Fertility and Sterility 2018;110: e141-e142.
Herlihy NS, Sekhon L, Lee JA, Stein D, Copperman AB, Lederman MA. Caring for BRCA Carriers: Strategies to Promote Health and Preserve Fertility. Journal of Women???s Health and Gynecology 2018; 5:101; e1-10.
Sekhon L, Rodriguez-Purata J, Lee JA, Whitehouse MC, Lederman M, Copperman AB. Ovarian reserve and embryonic aneuploidy rates in BRCA 1 and 2 carriers. Fertility and Sterility 2016; 106:e371.
Ganza AL, Whitehouse MC, Lee JA, McGovern PG, Lederman M, Copperman AB, Stein DE. Obesity and art: does BMI affect euploidy rates and/or pregnancy outcomes in couples undergoing IVF with CCS? Fertility and Sterility 2016; 106:e264.
Sekhon L, Rodriguez-Purata J, Aharon D, Lee JA, Whitehouse MC, Klein J, Lederman M, Grunfeld L, Mukherjee T, Copperman AB. Interpreting early HCG dynamics in the era of the thawed euploid single embryo transfer: how important is doubling? Fertility and Sterility 2016; 106:e341-342.
Kon M, Sekhon L, Shaia K, Whitehouse MC, Lee JA, Slifkin R, Flisser E, Klein J, Lederman M, Grunfeld L, Mukherjee T, Sandler B, Copperman AB, Stein DE. Number of supernumerary euploid embryos from an IVF cycle correlates with an ongoing pregnancy rate after subsequent single, euploid embryo transfer (SET). Fertility and Sterility 2016; 106:e202.
Keltz MD, Vega M, Sirota I, Lederman M, Moshier EL, Gonzales E, Stein D. Preimplantation Genetic Screening (PGS) with Comparative Genomic Hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriages. Journal of Assisted Reproduction and Genetics 2013;30:1333-1339.
Sauerbrun-Cutler M, Keltz M, Lederman M, Vega M, Stein DE. Serum anti-mullerian hormone levels decrease after Metformin administration in women with Polycystic Ovary Syndrome more in patients with lean PCOS despite their normal levels of insulin resistance. Reproductive Sciences 2013; 20(3):180A.
Breborowicz AK, Keltz, MD, Chau P, Stein D, Lederman M, Gonzales E. Transvaginal ovarian drilling (TVOD) for severe polycystic ovary syndrome (PCOS) prior to in vitro fertilization (IVF) dramatically improves IVF outcomes. Fertility and Sterility 2012;98:S212.
Sauerbrun-Cutler M, Lederman M, Keltz M, Lee M, Stein D. Serum anti-m??llerian hormone levels (AMH) decrease after metformin administration in women with both lean and overweight polycystic ovary syndrome (PCOS). Fertility and Sterility 2012;98:S213.
Breborowicz AK, Stein DE, Lederman MA, Keltz MD. Unilateral ovarian hypoplasia???A report of two cases. Open Journal of Obstetrics and Gynecology 2012;2:69-72.
Hachem LEl, Stein DE, Keltz MDM, Lederman MA. Ovarian Heterotopic Pregnancy after Ovulation Induction with Clomiphene Citrate. Gynecology & Obstetrics 2011;1:107.
Lederman MA, Lebesgue D, Gonzalez VV, Shu J, Merhi ZO, Etgen AM, Neal-Perry G. Age-related LH surge dysfunction correlates with reduced responsiveness of hypothalamic anteroventral periventricular nucleus kisspeptin neurons to estradiol positive feedback in middle-aged rats. Neuropharmacology 2010;58:314-320.
Neal-Perry G, Lebesgue D, Lederman M, Shu J, Zeevalk GD, Etgen A. The excitatory peptide kisspeptin restores the luteinizing hormone surge and modulates amino acid neurotransmission in the medial preoptic area of middle-aged rats. Endocrinology 2009;150: 3699-3708.
Merhi Z, Lederman M, Shu J, Etgen A, Neal-Perry G. Insulin-Like Growth Factor-1: A Neuroendocrine Role in Aging? Oral presentation at the Society for Neuroscience, Washington, D.C. 11/15/08-11/19/08.
Santoro N, Lederman M. Bleeding, Abnormal Uterine: Postmenopausal and Menopausal Transition. In: Hillard PJ, ed. The 5-Minute OB/GYN Clinical Consult. 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:14-15.
Lederman MA, Chuang M, Jindal SK, Pal L, Polotsky AJ, Santoro N. Three or more prior COH cycles: a poor prognostic predictor for 1st IVF-ET cycle in patients with unexplained infertility (UI). Fertility and Sterility 2007;88:S148-S149.
Pal L, Bowen S, Bevilacqua K, Soskin L, Lederman M, Santoro N. Higher reporting of sexual dissatisfaction by female partners in couples with male factor infertility. Fertility and Sterility 2005;84:S133.
Hurwitz JM, Lederman MA, Jindal SK, Lieman HJ, Santoro N. Embryo Donation (ED): an increasingly popular option in the United States. Fertility and Sterility 2005;84:S235-S236.